These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 2481240)
1. Improvement of histological and immunological change in steroid and immunosuppressive drug-resistant lupus nephritis by high-dose intravenous gamma globulin. Lin CY; Hsu HC; Chiang H Nephron; 1989; 53(4):303-10. PubMed ID: 2481240 [TBL] [Abstract][Full Text] [Related]
2. Improvement in steroid and immunosuppressive drug resistant lupus nephritis by intravenous prostaglandin E1 therapy. Lin CY Nephron; 1990; 55(3):258-64. PubMed ID: 2370925 [TBL] [Abstract][Full Text] [Related]
3. [Laboratory and morphologic parameters in patients with lupus nephritis]. Rasković S; Bogić M; Perić-Popadić A; Stefanović L; Arandjelović S; Jovicić Z; Bolpacić J; Tomić-Spirić V Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():38-41. PubMed ID: 12583312 [TBL] [Abstract][Full Text] [Related]
4. Renal immunofluorescence and the prediction of renal outcome in patients with proliferative lupus nephritis. Nossent H; Berden J; Swaak T Lupus; 2000; 9(7):504-10. PubMed ID: 11035415 [TBL] [Abstract][Full Text] [Related]
5. Clinical significance of necrosis in lupus nephritis. Makino H; Hayashi Y; Yamasaki Y; Shikata K; Kashihara N; Kira S; Ota Z Intern Med; 1994 Aug; 33(8):461-5. PubMed ID: 7803911 [TBL] [Abstract][Full Text] [Related]
6. Solubilization of intraglomerular deposits of IgG immune complexes by human sera or gamma-globulin in patients with lupus nephritis. Tomino Y; Sakai H; Takaya M; Miura M; Suga T; Endoh M; Nomoto Y Clin Exp Immunol; 1984 Oct; 58(1):42-8. PubMed ID: 6206971 [TBL] [Abstract][Full Text] [Related]
7. Identification of biomarkers that predict response to treatment of lupus nephritis with mycophenolate mofetil or pulse cyclophosphamide. Dall'Era M; Stone D; Levesque V; Cisternas M; Wofsy D Arthritis Care Res (Hoboken); 2011 Mar; 63(3):351-7. PubMed ID: 21080348 [TBL] [Abstract][Full Text] [Related]
8. [Effect of methylprednisolone pulse therapy in patients with lupus nephritis assessed by WHO morphologic classification]. Makino H; Yamasaki Y; Hayashi Y; Haramoto T; Shikata K; Kumagai I; Taniai K; Takahashi K; Ota Z Nihon Jinzo Gakkai Shi; 1990 Jul; 32(7):791-9. PubMed ID: 2273595 [TBL] [Abstract][Full Text] [Related]
9. Intravenous immunoglobulin treatment of lupus nephritis. Levy Y; Sherer Y; George J; Rovensky J; Lukac J; Rauova L; Poprac P; Langevitz P; Fabbrizzi F; Shoenfeld Y Semin Arthritis Rheum; 2000 Apr; 29(5):321-7. PubMed ID: 10805356 [TBL] [Abstract][Full Text] [Related]
10. Lupus nephritis in children--a review of 167 patients. Yang LY; Chen WP; Lin CY Pediatrics; 1994 Sep; 94(3):335-40. PubMed ID: 8065859 [TBL] [Abstract][Full Text] [Related]
11. Determination of circulating immune complexes, C3 and C4 complement components and anti-DNA antibody in different classes of lupus nephritis. Klein MH; Thorner PS; Yoon SJ; Poucell S; Baumal R Int J Pediatr Nephrol; 1984 Jun; 5(2):75-82. PubMed ID: 6333404 [TBL] [Abstract][Full Text] [Related]
12. Long term efficacy of high-dose intravenous methylprednisolone pulses in active lupus nephritis. A 21-month prospective study. Bertoni M; Brugnolo F; Bertoni E; Salvadori M; Romagnani S; Emmi L Scand J Rheumatol; 1994; 23(2):82-6. PubMed ID: 8165443 [TBL] [Abstract][Full Text] [Related]
13. Induction therapy with low-dose intravenous cyclophosphamide, oral mizoribine, and steroids for severe lupus nephritis in children. Fujinaga S; Kaneko K; Ohtomo Y; Murakami H; Takada M; Akashi S; Hira M; Yamashiro Y Pediatr Nephrol; 2005 Oct; 20(10):1500-3. PubMed ID: 16021476 [TBL] [Abstract][Full Text] [Related]
14. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis. Grootscholten C; Bajema IM; Florquin S; Steenbergen EJ; Peutz-Kootstra CJ; Goldschmeding R; Bijl M; Hagen EC; Van Houwelingen HC; Derksen RH; Berden JH; Arthritis Rheum; 2007 Mar; 56(3):924-37. PubMed ID: 17328070 [TBL] [Abstract][Full Text] [Related]
15. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis]. Cai XY; Yang XY; Chen XH; Liang LQ; Guan MM; Qin SG; Fu JZ Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1436-9. PubMed ID: 15500738 [TBL] [Abstract][Full Text] [Related]
16. Class IV-S versus class IV-G lupus nephritis: clinical and morphologic differences suggesting different pathogenesis. Hill GS; Delahousse M; Nochy D; Bariéty J Kidney Int; 2005 Nov; 68(5):2288-97. PubMed ID: 16221231 [TBL] [Abstract][Full Text] [Related]
17. Lupus nephritis in children: a longitudinal study of prognostic factors and therapy. Baqi N; Moazami S; Singh A; Ahmad H; Balachandra S; Tejani A J Am Soc Nephrol; 1996 Jun; 7(6):924-9. PubMed ID: 8793802 [TBL] [Abstract][Full Text] [Related]
18. [Instructions and implementations for percutaneous renal biopsy. Guidelines for the therapy of glomerular nephropaties]. Cagnoli L; G Ital Nefrol; 2003; 20 Suppl 24():S3-47. PubMed ID: 14666502 [TBL] [Abstract][Full Text] [Related]